Amjevita

List of products in the National Drug Code with proprietary name amjevita. Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis).

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
50090-6411Amjevita Adalimumab-attoInjectionSubcutaneousA-s Medication SolutionsHuman Prescription Drug
50090-6428Amjevita Adalimumab-attoInjectionSubcutaneousA-s Medication SolutionsHuman Prescription Drug
55513-399Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncHuman Prescription Drug
55513-400Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncHuman Prescription Drug
55513-410Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncHuman Prescription Drug
55513-411Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncHuman Prescription Drug
55513-413Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncHuman Prescription Drug
55513-479Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncHuman Prescription Drug
55513-480Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncHuman Prescription Drug
55513-481Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncHuman Prescription Drug
55513-482Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncHuman Prescription Drug
72511-400Amjevita Adalimumab-attoInjectionSubcutaneousAmgen Usa Inc.Human Prescription Drug
72511-482Amjevita Adalimumab-attoInjectionSubcutaneousAmgen Usa Inc.Human Prescription Drug